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Dear Editor,
Nevi are senescent and benign tumors of melano-
cytes, some of which can progress to melanoma (Gray-
Schopfer et al., 2007). BRAF
V600E is the most frequent
mutation in human nevi and melanoma, and promotes
senescence in human melanocytes (Gray-Schopfer
et al., 2007). The functional activity of BRAF
V600E has
been validated in both zebraﬁsh and mouse animal mod-
els (Damsky and Bosenberg, 2010; Patton et al., 2010).
Both models display nevus-like melanocytic hyperplasia;
however, the focus has been on the malignant transfor-
mation of these nevi to melanoma and not the nevi
themselves.
In zebraﬁsh, the transgenic expression of BRAF
V600E
from the mitfa promoter can promote ﬁsh-nevus
development, but an additional genetic mutation, for
example, in p53 is required to promote progression to
malignancy (Patton et al., 2005). BRAF
V600E nevi develop
in the young adult ﬁsh, and once formed remain static,
and do not continue to grow for the remainder of the life
of the ﬁsh. Thus, like in humans, ﬁsh-nevi appear to have
limited growth potential, most likely due to oncogenic
BRAF-induced senescence pathways. Even in BRAF
V600E
animals that are deﬁcient for p53, only some ﬁsh-nevi
progress to melanoma (Patton et al., 2005), suggesting
that the constraints on ﬁsh-nevus growth are robust and
that multiple cellular changes are required to promote
transformation to melanoma.
We were able to exploit the regenerative capacity of
the zebraﬁsh to explore the self-renewal potential of the
ﬁsh-nevus. The zebraﬁsh pigmentation pattern consists
of three pigment cell types: the melanocytes, the irido-
phores, and the xanthophores (Kelsh et al., 2009).
Partial amputation of the ﬁn tissue has previously been
studied to dissect the genetic pathways responsible for
melanocyte regeneration (Rawls and Johnson, 2000,
2001). Following microinjection of the BRAF
V600E trans-
gene into the single-cell embryo (mosaic transgenics),
nevi occur randomly, with a proportion in the caudal ﬁn
(Appendix S1). Zebraﬁsh ﬁn pigmentation patterns are
highly stereotyped, and zebraﬁsh-nevi are clearly distin-
guishable from normal patterning by ectopic dark, dif-
fusely pigmented and often larger melanocytes. This
allowed us to ask whether the constraints on ﬁsh-nevus
growth are maintained in the context of the regenerat-
ing ﬁn tissue. The distal portion of the caudal ﬁn was
amputated, removing between one-quarter and one-half
of the nevus, and the regrowth of the tail and ﬁsh-nevus
was recorded. We reasoned that there could be four
possible outcomes: nevus regrowth with the regenerat-
ing tail ﬁn, enhanced nevus regrowth with the regener-
ating tail ﬁn, no nevus growth with the regenerating tail
ﬁn, or regression of the remaining nevus.
Thirty-four zebraﬁsh displaying ﬁsh-nevi within the
caudal ﬁn underwent partial amputation (Figure 1B and
Table 1). Zebraﬁsh were imaged initially as a reference
image, immediately following partial nevus removal (Fig-
ure 1A, B) and subsequently at 1-week intervals for at
least 3 weeks post-surgery (Figure 1C–G). Four different
outcomes were observed (Table 1). The most frequent
outcome was complete regrowth of the nevus (regener-
ate; n = 32; Figure 1C–G). Regenerating ﬁn nevus tissue
carried the mitfa-BRAF
V600E transgene cells, as con-
ﬁrmed by genotyping of the regenerate ﬁn tissue (data
not shown). However, because the ﬁsh are mosaic
transgenics, non-nevus tail ﬁn tissue also carried and
expressed the transgene preventing us from determin-
ing the origin of the repopulating ﬁsh-nevus melano-
cytes. Fin regeneration without regrowth of the nevus
was also observed (n = 1; non-regenerate; Figure S1),
as was one case of nevus regression in which the
remaining segment of nevus appeared to regress leav-
ing the original stripe pattern evident (regression; Fig-
ure S2). Rates of ﬁsh-nevus regrowth could vary, but all
ﬁsh-nevi could be clearly seen to begin recurrence
within 1 week. Most ﬁsh-nevi had recurred by 3 weeks,
although one ﬁsh required up to 10 weeks for complete
regrowth. Three ﬁsh showed enhanced regrowth along
the length of the tail ﬁn (Figure S3). Thus, we ﬁnd that
most ﬁsh-nevi have the potential for recurrence within
the context of the regenerating tail ﬁn tissue.
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type background (AB or TE strains). We also tested
recurrence in zebraﬁsh disrupted for cell-to-cell contact
between pigment cells in the mutant line leopard (muta-
tion in connexin 41.8; (Watanabe et al., 2006) and in
zebraﬁsh that have ﬁn overgrowth (longﬁn; mutation in
kcnh2l; S. Johnson, personal communication). Fish-
nevus recurrence was recorded in all ﬁsh, regardless of
background (Table 1). Notably, ﬁsh-nevi could recur after
multiple and successive ﬁn amputations (up to at least
three times).
We then addressed the cell population that generates
the recurrent nevus. One possibility is that the differen-
tiated melanocytes in the remaining ﬁsh-nevus undergo
migration and⁄or proliferation to repopulate the regener-
ating ﬁn. Previous studies have shown that regeneration
of the pigment stripes following ﬁn amputation involves
unpigmented precursor cells (Lee et al., 2010; Rawls
and Johnson, 2000, 2001). Ten ﬁsh with regenerative
ﬁsh-nevi were selected, and recurrence was observed
in the presence of N-phenylthiourea (PTU) to block de
novo melanin synthesis (Figure 2). In this way, melanin
is used as a lineage tracer that pigments the new mela-
nocytes derived from division of original nevus cells or
allows for the visualization of migrating nevus cells into
the regenerating tail. We found that the tail ﬁns regener-
ated in PTU lack pigmentation of either the regenerating
stripes or nevus cells. Unpigmented cells did repopulate
the tail ﬁn; however, because upon the initiation of mel-
anin synthesis (24 h after removal of PTU), we observed
pigmented melanocytes in the tail ﬁn and the regener-
ated ﬁsh-nevus. This indicates that the melanocytes
responsible for repopulating the ﬁsh-nevus, at least in
the initial stages, are primarily derived from an unpig-
mented precursor cell type and not from signiﬁcant
migration or proliferation of differentiated pigmented
ﬁsh-nevus melanocytes.
Tail ﬁn regeneration did not promote melanoma in any
of the recurring ﬁsh-nevi. Notably, two nevi ﬁsh had
p53+⁄) mutations and also did not develop melanoma
(up to 3 months post-caudal ﬁn amputation) at the
regenerating nevus, despite developing tumors from
additional nevi elsewhere on the body (Table 1). Follow-
ing this, we wondered whether tail regeneration might
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Figure 1. Regeneration of a partially amputated ﬁsh-nevus. (A)
Mosaic integration of mitf-BRAF
V600E promotes ﬁsh-nevus
development in wild-type zebraﬁsh. Ectopic melanocytes form a
ﬁsh-nevus in the tail ﬁn (black tissue, ventral portion of tail ﬁn). The
red line indicates the line of amputation; the asterisk indicates an
additional ﬁsh-nevus on the body. (B) Amputation of a portion of
the tail ﬁn, removing the distal portion of the ﬁsh-nevus (ventral
portion of ﬁn) and normal ﬁn tissue (dorsal portion of ﬁn). The
regenerating tail ﬁn was imaged at 1-week intervals following
amputation. Regrowth of the tail ﬁn at 1 week (C), 2 weeks (D),
and 3 weeks (E). Higher-magniﬁcation image of the regenerating
tail ﬁn pigmentation in the normal tissue of the dorsal portion of
the ﬁn (F) and the regenerating ﬁsh-nevus (G). Yellow
xanthophores and black melanocytes are clearly visible in the tail
ﬁn regenerate. (H) Complete tail ﬁn and ﬁsh-nevus regeneration
at 4 months.
Table 1. Summary of BRAF
V600E zebraﬁsh nevus response
BRAF
V600E nevus response
Number of
zebraﬁsh
a
Recurrent 32
Original size
b 29
Larger size
c 3
Nonrecurrence 1
Regression 1
aAB⁄TE (12 wild-type ﬁsh; 2 p53
M214K+ ⁄ )), leopard (3) or longﬁn,
leopard (15), ranging in age from 3 months to 1.5 years.
bOriginal size recurrent nevi were scored as those nevi that at least
regained original nevus size in the regenerating tail ﬁn at 4 weeks.
Original size recurrent nevi genotypes: AB⁄TE (12 wild-type ﬁsh; 2
p53
M214K+ ⁄ )), leopard (3) or longﬁn, leopard (12).
cLarger size recurrent nevi were scored as those nevi that
appeared larger at 4 weeks than the original nevus. All larger size
recurrent nevi were observed in the longﬁn, leopard line.
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V600E
p53 lines in which all melanocytes carry the BRAF
V600E
transgene. We repeated our tail regeneration assay in
ﬁve stable transgenic BRAF
V600E ⁄ V600E p53)⁄) zebraﬁsh
and found no progression to melanoma at the tail ﬁn
(followed up to 4 weeks post-amputation; data not
shown). Likewise, amputation of the tail ﬁns in the
highly tumor prone RAS
V12 stable lines (Santoriello
et al., 2010) also did not stimulate tumorigenesis (fol-
lowed up to 3 weeks post-amputation; n = 24; data not
shown). Thus, in the proliferative environment of the
regenerating tail ﬁn, sufﬁcient cellular controls are main-
tained to prevent tumorigenesis in BRAF
V600E- and
RAS
V12-expressing melanocytes.
In conclusion, otherwise growth-restricted zebraﬁsh
ﬁsh-nevi have the potential to repopulate large portions
of a nevus from an unpigmented precursor cell type,
without promoting tumorigenicity. UV light exposure
and BRAF mutations contribute to nevus initiation in
humans but the maintenance, recurrence, and regres-
sion of nevi are not well understood. Nevi often regress
in older people (Tucker et al., 2002), and a proportion of
patients display nevi recurrence following removal by
surgical curettage or dermabrasion (King et al., 2009).
These recurrent nevi are not tumorigenic but can often
resemble a dysplastic nevus or melanoma (pseudomel-
anoma). The source of melanocytes that repopulate a
recurrent nevus is unknown, but it has been postulated
that the melanocytes may be derived from nearby mela-
nocyte stem cells or residual nevus melanocytes at the
site of removal (King et al., 2009). In our model, the
regenerative nevi appear to be derived from an unpig-
mented precursor population, at least during the ﬁrst
11 days of regeneration. The potential for differing
regenerative outcomes of the ﬁsh-nevi suggests that
ﬁsh-nevi may actively regulate and sustain their growth.
While we do not know how human nevus maintenance
compares with the zebraﬁsh-observed nevus outcomes,
this model provides a novel platform to study funda-
mental questions about nevus maintenance, regrowth,
and regression.
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Supporting information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. A nonrecurrent ﬁsh-nevus.
Figure S2. A regressive ﬁsh-nevus.
Figure S3. A recurrent ﬁsh-nevus with enhanced
regrowth.
Appendix S1. Materials and Methods.
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